SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001213900-23-050708
Filing Date
2023-06-22
Accepted
2023-06-22 06:12:18
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea180675-424b5_neurosense.htm 424B5 9678
2 GRAPHIC image_001.jpg GRAPHIC 14991
  Complete submission text file 0001213900-23-050708.txt   31452
Mailing Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562
Business Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562 972-9-9531142
NeuroSense Therapeutics Ltd. (Filer) CIK: 0001875091 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-269306 | Film No.: 231031468
SIC: 2834 Pharmaceutical Preparations